The Campbell's Company CPB
Verdict: Sell. Fair value $23.44 against a price of $26.67 on 5 Jan 2026, 12% below the price.
In plain words
The case for: Narrow competitive moat provides durability. Market leadership enables pricing power.
The case against: Intense competitive pressure could compress margins. Net Income exhibits significant volatility (e.g., a 34% drop from $0.86B in 2023 to $0.57B in 2024)....
Main risks
- Extremely High Leverage: A Debt/Equity ratio of 1.85 and an estimated Net Debt/EBITDA over 6x indicate significant financial risk and a fragile balance sheet.
- Deteriorating Profitability: Net margin has compressed from over 9% in 2023 to under 6% in 2025, and FCF margin shows a similar downtrend, suggesting eroding pricing power or cost control issues.
- Negative Return on Incremental Capital: The estimated 3-year ROIIC is negative (-14.2%), a severe red flag indicating that recent capital investments have been value-destructive, failing to generate incremental profits.
- Near-term debt maturity concerns
- Net Income exhibits significant volatility (e.g., a 34% drop from $0.86B in 2023 to $0.57B in 2024)...
- Intense competitive environment